• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻给予洛沙平后脑内分布和僵住现象:代谢在经鼻 CNS 药物的 PK/PD 中的作用。

Brain disposition and catalepsy after intranasal delivery of loxapine: role of metabolism in PK/PD of intranasal CNS drugs.

机构信息

School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Room 801C Lo Kwee-Seong Integrated Biomedical Sciences Building, Shatin, New Territories, Hong Kong.

出版信息

Pharm Res. 2013 Sep;30(9):2368-84. doi: 10.1007/s11095-013-1080-x. Epub 2013 Jun 7.

DOI:10.1007/s11095-013-1080-x
PMID:23739987
Abstract

PURPOSE

To elucidate the role of metabolism in the pharmacokinetics and pharmacodynamics of intranasal loxapine in conscious animals.

METHODS

At pre-determined time points after intranasal or oral loxapine administration, levels of loxapine, loxapine metabolites, and neurotransmitters in rat brain were quantified after catalepsy assessments (block test and paw test). Cataleptogenicity of loxapine was also compared with its metabolites.

RESULTS

Intranasally administered loxapine was efficiently absorbed into systemic circulation followed by entering brain, with tmax ≤15 min in all brain regions. Oral route delivered minimal amounts of loxapine to plasma and brain. Brain AUC0-240min values of 7-hydroxy-loxapine were similar after intranasal and oral administration. Intranasal loxapine tended to induce less catalepsy than oral loxapine, although statistical significance was not reached. The catalepsy score was positively and significantly correlated with the striatal concentration of 7-hydroxy-loxapine, but not with loxapine. 7-hydroxy-loxapine was more cataleptogenic than loxapine, while the presence of loxapine tended to reduce rather than intensify 7-hydroxy-loxapine-induced catalepsy. The increases in striatal dopamine turnover were comparable after intranasal and oral loxapine administration.

CONCLUSIONS

The metabolite 7-hydroxy-loxapine, but not loxapine, was the main contributor to the catalepsy observed after intranasal and oral loxapine treatment. Intranasal route could effectively deliver loxapine to brain.

摘要

目的

阐明代谢在清醒动物经鼻给予洛沙平的药代动力学和药效学中的作用。

方法

在经鼻或口服洛沙平给药后预定的时间点,在进行僵住评估(阻滞试验和爪试验)后定量测定大鼠脑内洛沙平、洛沙平代谢物和神经递质的水平。还比较了洛沙平与其代谢物的致僵作用。

结果

经鼻给予的洛沙平被有效地吸收到体循环中,然后进入大脑,所有脑区的 tmax≤15 分钟。口服途径向血浆和大脑输送的洛沙平最少。经鼻和口服给药后,7-羟基洛沙平的脑 AUC0-240min 值相似。经鼻洛沙平引起的僵住作用倾向于比口服洛沙平少,尽管未达到统计学意义。僵住评分与纹状体中 7-羟基洛沙平的浓度呈正相关且显著相关,但与洛沙平无关。7-羟基洛沙平比洛沙平更具致僵作用,而洛沙平的存在倾向于减轻而非加剧 7-羟基洛沙平引起的僵住作用。经鼻和口服洛沙平给药后,纹状体多巴胺周转率的增加相当。

结论

代谢物 7-羟基洛沙平,而不是洛沙平,是经鼻和口服洛沙平治疗后观察到的僵住的主要原因。经鼻途径可有效将洛沙平递送到大脑。

相似文献

1
Brain disposition and catalepsy after intranasal delivery of loxapine: role of metabolism in PK/PD of intranasal CNS drugs.经鼻给予洛沙平后脑内分布和僵住现象:代谢在经鼻 CNS 药物的 PK/PD 中的作用。
Pharm Res. 2013 Sep;30(9):2368-84. doi: 10.1007/s11095-013-1080-x. Epub 2013 Jun 7.
2
Investigation of the disposition of loxapine, amoxapine and their hydroxylated metabolites in different brain regions, CSF and plasma of rat by LC-MS/MS.采用 LC-MS/MS 法研究洛沙平、阿莫沙平及其羟基化代谢物在大鼠不同脑区、CSF 和血浆中的处置情况。
J Pharm Biomed Anal. 2012 Jan 25;58:83-93. doi: 10.1016/j.jpba.2011.09.020. Epub 2011 Sep 22.
3
Pharmacokinetic comparison between the long-term anesthetized, short-term anesthetized and conscious rat models in nasal drug delivery.长期麻醉、短期麻醉和清醒大鼠模型在鼻腔给药方面的药代动力学比较。
Pharm Res. 2014 Aug;31(8):2107-23. doi: 10.1007/s11095-014-1312-8. Epub 2014 Feb 20.
4
Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens.接受慢性稳定抗精神病药物治疗方案的受试者吸入洛沙平的多剂量药代动力学
J Clin Pharmacol. 2015 Sep;55(9):985-94. doi: 10.1002/jcph.502. Epub 2015 May 6.
5
Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats.氯氮平可抑制奥氮平和洛沙平诱导的僵住症,但会延长SCH 23390在大鼠中诱导的僵住症。
Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):361-4. doi: 10.1007/pl00004955.
6
Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects.在一项针对健康受试者的全面QT/QTc研究中,以热产生气雾剂形式给药的洛沙平不会延长QTc间期。
J Clin Pharmacol. 2014 Jun;54(6):665-74. doi: 10.1002/jcph.257. Epub 2014 Jan 22.
7
A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers.一项在健康志愿者中进行的吸入用洛沙平随机、安慰剂对照重复给药全面QT研究。
Int J Clin Pharmacol Ther. 2015 Nov;53(11):963-71. doi: 10.5414/CP202457.
8
Effect of smoking on the pharmacokinetics of inhaled loxapine.吸烟对吸入性洛沙平药代动力学的影响。
Ther Drug Monit. 2014 Oct;36(5):618-23. doi: 10.1097/FTD.0000000000000048.
9
Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.吸入用洛沙平用于紧急治疗与精神分裂症或双相情感障碍相关的急性激越。
Curr Med Res Opin. 2016 Jul;32(7):1253-60. doi: 10.1185/03007995.2016.1170004. Epub 2016 Jun 1.
10
Pharmacokinetics and Safety of Single-Dose Inhaled Loxapine in Children and Adolescents.儿童和青少年单剂量吸入洛沙平的药代动力学和安全性
J Clin Pharmacol. 2017 Oct;57(10):1244-1257. doi: 10.1002/jcph.932. Epub 2017 May 16.

引用本文的文献

1
Systematic Approach in the Development of Chitosan Functionalized Iloperidone Nanoemulsions for Transnasal Delivery, In Vitro and In Vivo Studies.系统方法在壳聚糖功能化伊洛哌酮纳米乳剂经鼻给药中的应用:体外和体内研究。
AAPS PharmSciTech. 2024 Oct 21;25(8):247. doi: 10.1208/s12249-024-02964-x.
2
Brain-Targeted Intranasal Delivery of Zotepine Microemulsion: Pharmacokinetics and Pharmacodynamics.唑替平微乳剂的脑靶向鼻腔给药:药代动力学和药效学
Pharmaceutics. 2022 Apr 30;14(5):978. doi: 10.3390/pharmaceutics14050978.
3
Thermo-sensitive hydrogels for delivering biotherapeutic molecules: A review.

本文引用的文献

1
Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions.中枢神经系统药物的区域选择性生物转化及其对药物不良反应的临床影响。
Expert Opin Drug Metab Toxicol. 2012 Jul;8(7):833-54. doi: 10.1517/17425255.2012.688027. Epub 2012 May 8.
2
Intranasal delivery of biologics to the central nervous system.经鼻内递送至中枢神经系统的生物制剂。
Adv Drug Deliv Rev. 2012 May 15;64(7):614-28. doi: 10.1016/j.addr.2011.11.002. Epub 2011 Nov 15.
3
Investigation of the disposition of loxapine, amoxapine and their hydroxylated metabolites in different brain regions, CSF and plasma of rat by LC-MS/MS.
用于递送生物治疗分子的热敏水凝胶:综述
Saudi Pharm J. 2019 Nov;27(7):990-999. doi: 10.1016/j.jsps.2019.08.001. Epub 2019 Aug 5.
4
The Gut Microbiome and Treatment-Resistance in Schizophrenia.肠道微生物组与精神分裂症的治疗抵抗。
Psychiatr Q. 2020 Mar;91(1):127-136. doi: 10.1007/s11126-019-09695-4.
5
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.研究吸入用洛沙平用于成人精神分裂症或双相I型障碍相关激越急性治疗的安全性、有效性及患者可接受性。
Neuropsychiatr Dis Treat. 2019 Aug 7;15:2273-2283. doi: 10.2147/NDT.S173567. eCollection 2019.
6
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.吸入性洛沙平在精神疾病患者急性激越治疗中的作用:一项临床综述
Int J Mol Sci. 2017 Feb 8;18(2):349. doi: 10.3390/ijms18020349.
7
Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: a pharmacokinetic and pharmacodynamics study.野葛(葛根)抑制华法林的抗凝作用:一项药代动力学和药效学研究。
Chin Med. 2016 Feb 27;11:7. doi: 10.1186/s13020-016-0078-9. eCollection 2016.
采用 LC-MS/MS 法研究洛沙平、阿莫沙平及其羟基化代谢物在大鼠不同脑区、CSF 和血浆中的处置情况。
J Pharm Biomed Anal. 2012 Jan 25;58:83-93. doi: 10.1016/j.jpba.2011.09.020. Epub 2011 Sep 22.
4
Diencephalic and brainstem mechanisms in migraine.偏头痛的间脑和脑干机制。
Nat Rev Neurosci. 2011 Sep 20;12(10):570-84. doi: 10.1038/nrn3057.
5
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.经鼻给予利培酮固体脂质纳米粒实现脑靶向。
J Drug Target. 2011 Jul;19(6):468-74. doi: 10.3109/1061186X.2010.523787. Epub 2010 Oct 19.
6
Beneficial effects of loxapine on agitation and breathing patterns during weaning from mechanical ventilation.氯氮平对机械通气撤机过程中激越和呼吸模式的有益影响。
Crit Care. 2010;14(3):R86. doi: 10.1186/cc9015. Epub 2010 May 12.
7
Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.三叉神经通路将一种低分子量药物从鼻腔输送到大脑和口腔结构。
Mol Pharm. 2010 Jun 7;7(3):884-93. doi: 10.1021/mp100029t.
8
Intranasal delivery--modification of drug metabolism and brain disposition.鼻腔给药——改变药物代谢和脑内分布。
Pharm Res. 2010 Jul;27(7):1208-23. doi: 10.1007/s11095-010-0127-5. Epub 2010 Apr 6.
9
Behavioral indices in antipsychotic drug discovery.抗精神病药物研发中的行为学指标。
J Pharmacol Exp Ther. 2010 Jun;333(3):632-8. doi: 10.1124/jpet.110.166710. Epub 2010 Mar 3.
10
Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting.基于粘膜粘附纳米乳剂的奥氮平脑靶向鼻内给药系统
J Drug Target. 2008 Dec;16(10):806-14. doi: 10.1080/10611860802476504.